We advertise our grants annually in the scientific journal 'Nature'. In 2009 the grant round opened in August.
Anyone interested in applying for a CGD research grant has to first complete a preliminary application. Preliminary applications are reviewed by members of our medical panel and three lay reviewers from our Trustee board who rate the applications according to relevance to the charity’s research strategy and whether the science is likely to lead to benefit for the CGD community. At this stage approximately 30-50% of the applications are rejected.
Successful applicants are then asked to submit a full application. Three external independent experts with related research experience reviews each application. Independent experts are chosen that have no affiliation to the grant applications and are asked to declare any conflict of interest in being a reviewer before receiving an application. All reviewers are expected to respect the applicants' confidentiality. The Trust provides guidance to the referees and supplies them a review form for this process. Peer reviewers are asked to score the applications on the basis of quality, relevance, originality, feasibility and value for money.
The Trust’s Medical and Scientific Advisory Panel consider the external reviewers' recommendations. The panel advises the Trust on the best quality research to fund and on setting priorities for future CGD research. We have in place a conflicts of interest policy and a register of interests for CGD RT's Medical and Scientific Advisory Panel by which all members agree to abide before joining the panel. Panel members can serve up to a maximum of six years on the panel.
Conflicts of interest document
The Association of Medical Research Charities approves all our peer review methods and in 2006 the CGD Research Trust received a certificate of best practice for its peer review procedures.
Our Medical and Scientific Advisory Panel
- Professor Maggie Dallman, Head Section of Immunology and Infection, University College London
- Dr Majlinda Lako, Senior Lecturer, Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne
- Professor Tom Rogers, Head of Clinical Microbiology, Trinity College Dublin, St James's Hospital, Dublin
- Professor Dirk Roos, Dept. of Blood Cell Research, Sanquin Research Centre, Amsterdam
- Professor Adriano Rossi, Professor of Respiratory and Inflammation Pharmacology, MRC Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh Medical School, Edinburgh
- Professor Reinhard Seger, Consultant paediatrician, Children's Hospital, Zurich
- Professor Len Seymour, Professor of Genetic Therapies, President of the British Society for Gene Therapy, University of Oxford
- Dr Simon Travis, Clinical Director of Gastroenterology and Endoscopy, John Radcliffe Hospital, Oxford
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2007 The Chronic Granulomatous Disorder (CGD) Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Site Map | Terms and Conditions | Privacy
